4//SEC Filing
Walkey Carl 4
Accession 0001209191-21-022929
CIK 0001404644other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 6:48 PM ET
Size
7.0 KB
Accession
0001209191-21-022929
Insider Transaction Report
Form 4
Walkey Carl
Senior Vice President
Transactions
- Sale
Common Stock
2021-03-24$11.95/sh−1,800$21,516→ 1,367,962 total - Sale
Common Stock
2021-03-22$12.00/sh−600$7,200→ 1,369,762 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]Represents the weighted average sale price. The lowest price at which shares were sold was $11.93 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001843189
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 6:48 PM ET
- Size
- 7.0 KB